Podcast: Improving Drug Development Speed with AI
Improving Drug Development Speed with AI in Life Sciences - with Emmanuel Walckenaer of YSEOP and Dan Faggella from Emerj
Listen and learn from two Artificial Intelligence (AI) subject matter experts. Yseop CEO, Emmanuel Walckenaer recently sat down with Dan Faggella from Emerj to discuss how NLP technology is impacting the clinical trial process. They analyzed the ramifications of Covid-19 on the drug introduction process and looked at what pharmaceutical companies are doing to better leverage and implement AI technology.